Author - Ziad

Pyramid Biosciences to Present at the 2022 Jefferies London Healthcare Conference

Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, announced today that Chief Executive Officer, Brian Lestini, M.D., Ph.D., will present at the 2022 Jefferies London Healthcare Conference on Thursday, November 17, 2022 at 2:40 PM GMT. Read more >>
Read more...

Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced top-line clinical results for its Phase II COVID-19 “universal” booster vaccine, AKS-452. An interim analysis of the data found that 93% of subjects previously vaccinated with Pfizer, Moderna, Johnson & Johnson (Janssen), and AstraZeneca vaccines showed an increase in neutralizing antibody titers after receiving a single dose of AKS-452. The average neutralization titers across all subjects increased 4-fold against the Wuhan strain and 5-fold against the Omicron...
Read more...

Legally blind man can see 20/20 vision again and inspires others with his story

More than 280,000 Ohioans are considered legally blind. Luckily for some, there are medical devices available to help correct their vision. Aside from it being extremely expensive getting a pair of these glasses, which is through the company, 'eSight', Benjamin Murray explained being legally blind comes with a long list of challenges in itself. "You know, it's hard to think about everyday life when you can't see," 33-year-old Murray said. He was considered legally blind for 26 years. In 2015,...
Read more...

U.S. Senator Richard Blumenthal (D-CT) Tours Landsdowne Labs

“Children swallow button batteries. That’s the reality of our world. Because the batteries become loose from devices, and then can literally burn through the throat of a young child. It happens again and again…[leading to] years of treatment, surgery, and therapy.” So said U.S. Senator Richard Blumenthal, D-CT, on an October 7 visit to Landsdowne Labs, at Fairfield University, in Fairfield, CT. Link to video of remarks. Landsdowne has since received a patent for technology that rapidly reduces chemical reactions...
Read more...

At the Forefront of Change says Ziad Moukheiber

"It is our responsibility as the Angel Investing community to be at the forefront of change #investingforabetterwork. We have no choice but to change our habbits to set a good example. Travel less and to see friends and family not for a one hour meeting! Cut plastics out of our lives! Fix things don’t buy new! And more… It is shocking to see the irreversible damage made to the environmen t! The list is long of what we can do and what we...
Read more...

CleanFiber seeks approval for expansion project in Hamburg

CleanFiber Buffalo – which won $500,000 in the state-funded business-plan competition in 2016 as UltraCell – is planning to construct a 5,250-square-foot metal panel addition to its existing 60,000-square-foot masonry-and-panel building at 250 Lake Ave., bringing the total size to 66,000 square feet. That will give the company more room for material handling, as well as new equipment, as part of what CEO Jonathan Strimling described as a $15 million investment in the facility. The project will be reviewed at...
Read more...

From the bottom of rocks to the halls of Harvard, this CEO has been looking for a new way to feed fish

After founding alternative feed ingredients biotech firm KnipBio in 2013, Larry Feinberg, a baseball loving, mountain biker, says he has brought the business to the cusp of commercialization. "It all looks like a straight line in the rear view mirror, as you are driving it might be a little windy," Feinberg said, reflecting on his life and career so far. Read more >>
Read more...